BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15382338)

  • 1. Endocrine Tumors of the Pancreas in Transgenic Mice.
    Longnecker DS
    Comp Med; 2004 Feb; 54(1):21-2. PubMed ID: 15382338
    [No Abstract]   [Full Text] [Related]  

  • 2. Models of Exocrine Pancreatic Neoplasms in Transgenic Mice.
    Longnecker DS
    Comp Med; 2004 Feb; 54(1):18-21. PubMed ID: 15382335
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.
    Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y
    J Biosci Bioeng; 2007 Jul; 104(1):14-21. PubMed ID: 17697978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation, hyperplasia, neogenesis, and neoplasia in the islets of Langerhans.
    Ballian N; Hu M; Liu SH; Brunicardi FC
    Pancreas; 2007 Oct; 35(3):199-206. PubMed ID: 17895838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.
    Müller-Decker K; Fürstenberger G; Annan N; Kucher D; Pohl-Arnold A; Steinbauer B; Esposito I; Chiblak S; Friess H; Schirmacher P; Berger I
    Gastroenterology; 2006 Jun; 130(7):2165-78. PubMed ID: 16762637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-beta1.
    Moritani M; Yamasaki S; Kagami M; Suzuki T; Yamaoka T; Sano T; Hata J; Itakura M
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):175-84. PubMed ID: 15607541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
    Hruban RH; Adsay NV; Albores-Saavedra J; Anver MR; Biankin AV; Boivin GP; Furth EE; Furukawa T; Klein A; Klimstra DS; Kloppel G; Lauwers GY; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Pérez-Gallego L; Redston M; Tuveson DA
    Cancer Res; 2006 Jan; 66(1):95-106. PubMed ID: 16397221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Creation of diet-dependent cancer models in transgenic animals].
    Cartier N; Briand P; Kahn A
    Bull Acad Natl Med; 1994 Jan; 178(1):23-32; discussion 32-4. PubMed ID: 8038992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and utilization of transgenic animal models in studies of pancreatic cancer. Pancreas Cancer Working Group.
    Pancreas; 1987; 2(4):470-2. PubMed ID: 3650908
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular changes in pancreatic cancer.
    Buchholz M; Gress TM
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1487-97. PubMed ID: 19828010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumours of the pancreas.
    Dixon D; Maronpot RR
    IARC Sci Publ; 1994; (111):281-303. PubMed ID: 8082910
    [No Abstract]   [Full Text] [Related]  

  • 13. Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis.
    Casanovas O; Hager JH; Chun MG; Hanahan D
    Oncogene; 2005 Oct; 24(44):6597-604. PubMed ID: 16007165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign and malignant lymphoproliferative processes associated with the murine islet system].
    Freytag G; Kolb-Bachofen V; Kiesel U; Kolb H
    Verh Dtsch Ges Pathol; 1981; 65():255-61. PubMed ID: 6750953
    [No Abstract]   [Full Text] [Related]  

  • 15. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer.
    Hanahan D; Wagner EF; Palmiter RD
    Genes Dev; 2007 Sep; 21(18):2258-70. PubMed ID: 17875663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumors of the pancreas].
    Shchegolev AI; Paklina OV; Galil-Ogly GA
    Arkh Patol; 2006; Suppl():2-48. PubMed ID: 16856369
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endocrine tumor arising in heterotopic gastric pancreas].
    Denève E; Ramos J; Aufort S; Marchand JP; Rousset T; Perrochia H; Domergue J; Navarro F
    Gastroenterol Clin Biol; 2008 Feb; 32(2):195-201. PubMed ID: 18387430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
    Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
    J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic technologies.
    Montag A
    Anat Rec; 1993 May; 236(1):147-50; discussion 150-1. PubMed ID: 8507000
    [No Abstract]   [Full Text] [Related]  

  • 20. A rapid procedure to evaluate foreign DNA transfer into mammals.
    Pinkert CA
    Biotechniques; 1990 Jul; 9(1):38-9. PubMed ID: 2203385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.